GLOBAL PV (NEW)
From value assessment to regulatory harmonization, the Global PV focus of our program will address the approached to internationalization of pharmacovigilance approaches as the industry penetrates new markets for medicines and medical devices.
PREDICTIVE SAFETY (NEW)
Bringing together toxicology, translational data, trial design, and model selection to help your company increase the accuracy of safety predictions.
No other conference addresses the evolving landscape of safety for medical devices from a practical and innovative perspective. This bold focus of our program will bring pharma, biotechs, medical device developers and regulatory agencies to discuss the need for modern regulation that meet patient safety needs.
NEXT GEN TECH & DATA
Innovation in technology, data, evidence, artificial intelligence and machine learning are the key areas explored by the industry in our program as they promote approaches in data collection methods, signal detection, automation, adoption and implementation.
By shifting “patient centricity” from rhetoric into practical applications, the industry will examine patient management and patient safety profiles and analyze their effects on safety with a focus on improving the patient experience as a whole.
Through a focus on risk assessment, the Heads of Safety and PV will debate and brainstorm about the needed organizational structure, technology infrastructure, regulatory approach, and ways to improve post-market authorization, risk in the drug development life-cycle and pharmacoepidemiology.